Introduction
Malaria is still one of the most serious health problems in Profound perturbations of the immune system are observed during the infection such as (i) hypergammaglobulinemia, developing countries. The infection is contracted through the bite of an infected mosquito which releases sporozoites into with a lack of plasmodial specificity resulting from a polyclonal B cell activation (19, 20) , and (ii) induction of hyporesponsivethe blood stream. Sporozoites invade host hepatocytes, where they differentiate giving rise to multinucleated schizonts.
ness of T cells to plasmodial and non-plasmodial antigens, and perturbation of the CD4/CD8 ratio (21) (22) (23) . The cause of Mature liver schizonts release merozoites able to invade erythrocytes and initiate the erythrocytic phase of the infection.
this phenomenon is not known, nevertheless there is evidence of a defect in both production of IL-2 and expression of IL-2 The erythrocytic stages are mainly responsible for the pathology associated with the disease (reviewed in 1).
receptor by peripheral blood lymphocytes in response to stimulation with malaria-specific antigen during acute PlasImmunity to malaria parasites is stage-specific and develops slowly even for those living in endemic areas. This modium falciparum malaria in humans (24). It has been suggested that the strong polyclonal activation immunity is never complete, and is reflected by reduced clinical symptoms and low parasitemia. The immunology of of all lymphocyte populations observed during malaria infection is due to a mitogen released by Plasmodium (25) . To date, the disease is far from being fully understood, but it is clear that αβ T cells and B cells are important in regulating and no evidence has been provided concerning the existence of such a mitogenic molecule in human or rodent Plasmodium maintaining immune responses to parasite exo-erythrocytic and erythrocytic stages (2, 3) . The evidence of a role for T species. Erythrocytic stages of P. falciparum parasites have been shown to be able to stimulate in vitro proliferation of γδ cell immunity in controlling malaria infection has been derived from both animal and human models (4-13). T cells have T cells from non-exposed donors, and especially those T cells using V γ 9 and V δ 2 (26,27). Since only V γ 9 ϩ T cells were been implicated to a great extent in the pathology of the disease (14, 15) , and cytokines such as tumor necrosis factor stimulated it was suggested that the γδ T cell response to P. falciparum was due to a superantigen since it induced a and IFN-γ have also been shown to play a critical role in resistance to infection (16-18).
response MHC class II molecules. The in vitro observation was underlined by the fact that the V γ 9 ϩ T cell subset Lymphocyte preparations and staining increased in the blood of individuals undergoing primary P.
Blood, lymph nodes (LN) and spleens were removed from falciparum infection (28,29).
control uninfected mice and mice injected with sporozoites In general, superantigens from a number of pathogens 3, 10 and 30 days before injection. In the case of mice stimulate T lymphocytes through particular TCR V β chains injected with pRBC, organs were taken 7 and 30 days post-(reviewed in 30). The recognition of T cells depends almost infection. LN cells and splenocytes suspensions were treated exclusively on the V β domain and, consequently, a supertwice with ACK (ammonium chloride/potassium) buffer to lyse antigen can interact with a large fraction of the T cell repertoire, erythrocytes and washed twice with PBS containing 3% because the number of V β genes is low (31) . In contrast to FCS (Gibco/BRL, Cergy-Pontoise, France). Lymphocytes from conventional antigens, superantigens bind specifically with a peripheral blood were isolated on Ficoll-Hypaque solution region of TCR located on the V β chain, outside of the specific (Pharmacia) and washed twice with PBS/FCS before counting. site which combines with the MHC-peptide complex (32, 33) .
For cytofluorometric analysis, lymphocytes were incubated When superantigens are encountered during T cell developfirst with biotinylated mAb directed against the V β chain ment they usually induce a clonal deletion, or an anergy, of and subsequently with anti-CD3-FITC, anti-CD4-FITC or anti-T cells bearing the appropriate V β (34).
CD8-FITC in the presence of phycoerythrin-conjugated strepIn order to identify T cell populations and define the T cell tavidin. repertoire involved in the host response to malaria infection, Flow cytometric analysis we have studied TCR V β chain usage in different cell compartments of C57BL/6 mice infected either with sporozoites or Cell analysis was done with a FACScan cytofluorometer erythrocytic stages of Plasmodium. We describe here a (Becton Dickinson, Grenoble, France) using Lysis II software. superantigenic-like activity associated with the parasite.
Viable lymphocytes were carefully gated by light scatter (FSC/SSC), and for all V β analysis 5000-10,000 events were acquired and recorded per sample. Thymidine incorporation was determined by beta counting animals were injected with sterile PBS. Parasitemia was (Beckman, Gagny, France). monitored by detecting parasites every day on blood smears after Giemsa staining.
IL-2 production assay IL-2 production of T cells from mice treated with various Antibodies stimuli was tested using an IL-2-dependent T cell line (CTLL-2) mAb specific for mouse CD3 (hamster anti-CD3 mAb 2C11), stimulated with medium alone, or supernatant from cells CD4 (rat anti-CD4 mAb GK1. Differences between groups were analyzed by Student's t-test and χ 2 using the STAVIEW software. (47) were all biotinylated. Results but only in the group of mice which received pRBC. The increase of CD3 ϩ T cells and particularly by the CD4 ϩ Phenotypic analysis of T cells from mice infected with P. yoelii subpopulation observed during the parasitemia is maintained in the group of mice infected with pRBC, even after mice The distribution of lymphocyte subpopulations was examined by cytofluorometry in different cell compartments of C57BL/6 recovered from the infection. In the spleen of mice inoculated either with sporozoites or pRBC, the infection was also mice infected either with sporozoites or pRBC of P. yoelii 265 BY. Numbers of CD3 ϩ , CD4 ϩ and CD8 ϩ T cells were associated with an increase of CD4 ϩ T cells with time, even after remission (Table 3) . In parallel, a significant fall in the determined for blood, LN and spleen at days 3, 10 and 30 after infection with sporozoites, and days 7 and 30 after number of T cells bearing the CD8 marker was observed, particularly in the group of mice inoculated with sporozoites. parasitized erythrocyte inoculation. A significant change was observed in the number of CD3 ϩ T cells in peripheral blood
This drop in CD8 ϩ T cells was maintained, even 30 days after parasite infection. lymphocytes at day 10, in the group of mice infected with sporozoites, and at day 7 after pRBC inoculation. This increase V β TCR repertoire of CD3 T cells during infection by P. yoelii affects both CD4 ϩ and CD8 ϩ T cell subsets (Table 1 ). In the LN compartment, the number of CD3 lymphocytes is slightly
In order to determine whether the TCR V β gene usage was disturbed by infection with malaria parasites, the in vivo affected during the acute phase of the parasitemia (day 10 in mice injected with sporozoites and day 7 in those inoculated responses were assessed by enumerating T cells using different V β in both LN and blood at various times after parasite with parasitized erythrocytes) ( Table 2 ). The principal modification seen was a net increase of CD4 ϩ T cells (1.6 times inoculation. We have observed a slight increase of V β 8-bearing T cells in blood of mice injected with pRBC at day more than controls in sporozoite-inoculated mice and three times more in mice inoculated with pRBC). The number of 10 and 30, and in LN of mice infected with sporozoites at day 3 ( Fig. 1) . Experiments to understand this phenomenon CD8 ϩ T cells was also affected by the parasite development, are in progress and will be reported later. Moreover, as shown or pRBC, as compared with control mice. Thirty days after parasite inoculation, when mice had recovered from the in Fig. 1 , even as soon as day 3 of infection with P. yoelii sporozoites, the frequency of CD3 ϩ V β 9-bearing T cells was disease, expression of CD3 ϩ V β 9-bearing T cells was restored in both the blood and LN of parasitized mice at a level significantly decreased in the LN. This CD3 ϩ V β 9 ϩ T cell decrease was also observed at day 10 in both lymphoid comparable to controls. These results suggested the occurrence of a superantigenic activity associated with the prescompartments tested in mice infected either with sporozoites observed following the in vivo priming with both types of antigen preparation when compared to control mice which had received complete Freund's adjuvant alone. In each is an active phenomenon which requires live parasites. V β 9 deletion in mice neonatally infected with P. yoelii To confirm that the deletion of V β 9-bearing T cells resulted from superantigenic activity associated with the P. yoelii ence of P. yoelii parasites. It is worthy to note that the deletion of V β 9-bearing T cells was observed in the LN very soon after infection, we analyzed the expression of different V β chains (including V β 9) in C57BL/6 mice injected 48 h after birth with parasite inoculation (day 3), and that there was a close relationship between the deletion at the periphery and the either developmental stage of live parasites (sporozoite or pRBC). In parallel, a group of mice of the same age received presence in blood of the replicating parasite during which specific malaria antigens are released.
an injection of sporozoite lysate (the number of sporozoites present in the lysate being the same as the number of live To determine the population of blood and LN T cells affected by the V β 9 deletion, we have analyzed the frequency of sporozoites used to infect the mice in the first group). Four weeks later the expression of V β 9 in the thymus and peripheral expression of the V β 9 chain among CD4 ϩ and CD8 ϩ T lymphocytes at day 10 which corresponds to the peak of blood lymphocytes of mice belonging to the different groups was analyzed. As shown in Fig. 4 , a deletion of V β 9 ϩ T cells parasitemia in infected mice. The results of this analysis are shown in Fig. 2 . The deletion of V β 9-bearing T cells affects was observed in the peripheral blood lymphocytes of neonatal mice parasitized with either sporozoites or pRBC, but not in both CD4 ϩ and CD8 ϩ T subsets in mice infected either with sporozoites or with erythrocytic stages as compared to the mice that received just lysed parasites. By contrast, no V β deletion was observed for peripheral T cells other than V β 9, control group.
as is exemplified in Fig. 4 by V β 14. It is noteworthy that a V β 9 T cell response to sporozoites and pRBC antigens deletion in the thymus was not observed. In parallel, we examined the proliferative capacity of mesenIn order to analyze the mechanisms involved in the V β 9 deletion, mice were injected in their footpads with either teric LN T cells from control and mice neonatally infected either with lysed or live sporozoites, or with pRBC in the lysed sporozoites or lysed pRBC homogenates emulsified in complete Freund's adjuvant and 10 days later lymphocytes presence of concanavalin A or anti-CD3, anti-V β 8 or anti-V β 9 mAb coated on the surface of culture plates. Data represented were isolated from popliteal LN. Proliferation of T cells was observed in the BALB.D2 Mls a mice, a congenic strain which susceptible to the infection than BALB/c, since the peak of parasitemia and its duration were greater in these mice (mean peak of parasitemia was 15% in BALB.D2 between days 9 and 11 compared to 7.5% in BALB/c around day 8-9). in Fig. 5 show that after 4 days of proliferation, T cells from mice which have been exposed after birth to a lysed sporozoite preparation conserved their potential to proliferate upon stimuDiscussion lation with concanavalin A or antibodies directed against CD3, V β 8 and V β 9 chains. In contrast, T cells from mice
In this report, we have examined TCR V β usage during a murine experimental malaria infection. Using two-color flow neonatally infected with live parasites have partially lost their capacity to respond in vitro against these stimuli. This loss in cytometry, we have assessed the percentage of cells utilizing the different V β families in peripheral blood lymphocytes and the response could be due to the partial unresponsiveness of T cells after infection (48) (49) (50) . However, the anti-V β 9
LN of C57BL/6 mice infected either with sporozoites or with erythrocytic stages of P. yoelii at 3, 10 and 30 days after antibody was unable to stimulate T cells from infected mice to the same level as that observed with anti-CD3 or anti-V β 8 parasite inoculation. The results obtained are consistent with a parasite superantigenic like-activity during the acute malaria antibody. This shows that the residual V β 9-bearing T cells which are not deleted are anergized. This observation was infection. By day 3 after inoculation, mice which had been exposed to sporozoites showed a preferential deletion of a confirmed by the low level of IL-2 concentrations in the culture supernatants (data not shown).
LN CD3 ϩ V β 9-bearing T cell subset. This deletion is also observed on day 10 of infection in both peripheral blood The results obtained in neonatally infected mice confirm a V β 9-specific superantigenic activity associated with infection lymphocytes and LN of mice infected either with sporozoites or with parasitized erythrocytes. The effect is not I-E dependby P. yoelii. They also confirm that this activity is only detectable when the parasite is alive. ent, as it was shown for some superantigens (52) since it was observed with both BALB/c (H-2 d ) and C57BL/6 (H-2 b ) strains. Course of parasitemia in V β 9-deleted mice
The superantigenic activity which was observed is not due to bacterial, viral or fungal contaminants of the mosquito We have addressed the question of the direct or indirect interference of V β 9-bearing T cells in the susceptibility to salivary glands from which the sporozoites were isolated, because the same activity was also associated with the infection by P. yoelii. For this purpose, in a first step, we have verified in the BALB/c strain that the V β 9 ϩ T lymphocytes infection developed after pRBC inoculation. Moreover, no activity was detectable with a lysed sporozoite homogenate. were indeed deleted during the infection by the parasite (data not shown). Next, we have taken the course of parasitemia With many exogenous superantigens, the in vivo T cell response is characterized, in adult animals, by an initial in BALB/c mice as a control and compared it to parasitemia In order to confirm the superantigenic activity observed during malaria infection, sporozoites or erythrocytic stages of before the clonal deletion or anergy of this target subset (53) . By contrast, the deletion of V β 9-bearing T lymphocytes P. yoelii were injected into newborn C57BL/6 mice. Four weeks later we observed deletion and anergy of peripheral V β 9 ϩ T induced by a molecule associated with P. yoelii infection is not preceded by any detectable T cell expansion. This cells, with no effect detectable in the thymus. In general, neonatal injection of bacterial or viral superantigen induces observation is reminiscent of the detailed work on the in vivo expression of different V β in response to a superantigen a V β -specific clonal deletion of T cells expressing the reactive V β domain during thymic maturation, as well as at the peri-(staphylococcal enterotoxin A) (54) . It was observed that repeated injections of very small doses of the superantigen phery. However, by the use of several congenic strains, carrying the MMTV (C3H) superantigen as a transgene and caused almost complete deletion of the T cells bearing the target V β , with the absence of any prior T cell expansion.
expressing it at different levels, it was recently shown that a low level of superantigen transgene expression has no effect By analogy, we suggest that the plasmodial superantigenic activity probably acts also at a very low concentration and is on the target V β 14 ϩ T cells in the thymus, although the superantigen is expressed sufficiently to delete V β 14 ϩ T cells released by the parasite at different stages of its development, since its activity is detectable after inoculation of either in the periphery (59). Our results showing the occurrence of superantigenic activsporozoites or pRBC. Alternatively, it is possible that the parasite has an effect on host cells, by an unknown mechanity during the infection by P. yoelii raises the question of its role in the infectivity of the parasite, or in the pathogenesis of ism, in such a way that some of these cells are directly or indirectly activated to synthesize, at low concentration, an the infection, or in both. Therefore, we have analyzed the course of infection in BALB.D2 mice, a BALB/c congenic for 'endogenous' superantigen.
The in vivo response to bacterial toxins usually results in a Mls a which deletes V β 9. When compared to BALB/c, the infectivity of the P. yoelii is increased in BALB.D2 mice. This preferential deletion, or anergy, in the responding CD4 ϩ subpopulation; although some exceptions have been result can be compared with data obtained in the same strains of mice with a viral superantigen. The nucleocapsid observed where both CD4 ϩ and CD8 ϩ subsets are affected (55) . The infection with exogenous MMTV is dominated by of the rabies virus has been shown to delete the CD4 ϩ V β 6-bearing T cells and it was observed that BALB.D2 (which deletion or anergy in the responding CD4 ϩ lymphocytes (56) . In the murine model of Chagas' disease, the in vivo also presents a deletion for V β 6) is less susceptible than the BALB/c strain to the pathogenesis of the central nervous Trypanosoma cruzi superantigenic effect was observed in the CD8 compartment (57) . In a second parasitic system which system (60) . Since the superantigenic activity of the rabies virus was not associated with live intact virus, in contrast concerns Toxoplasma gondi, the in vitro response to a superantigen is restricted to CD8 ϩ lymphocytes (58) . By contrast, to our observations in malaria where live parasites were necessary, the comparison between the two cannot be the P. yoelii superantigenic activity affects both V β 9 ϩ CD4 ϩ and CD8 ϩ subsets. Again, by analogy with the effects taken further. The system that we have described in this paper offers a obtained in the chronic exposure to low dose of SEA (discussed above) which results in the disappearance of CD4 ϩ and good model to study the potential role of superantigens during primary malaria infection in correlation with susceptibility. CD8 ϩ T cells bearing V β 3, we can hypothesize that the plasmodial superantigen is expressed at low levels during Superantigens may play a role in host susceptibility to the establishment of a chronic infection after a single inoculation the time of the infection.
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